USP39 and central nervous system cancer: However, this activity is independent of canonical Hippo signaling, and is instead due to its ability to enhance pre-mRNA splicing of TAZ. Finally, our work provides an important basis for the development of diagnostic and therapeutic approaches in the treatment of glioma patients using USP39.